Skip to main content

Table 2 Baseline clinical characteristics of patients

From: Use of glucocorticoids in patients with acute respiratory distress syndrome: a meta-analysis and trial sequential analysis

Study

Study groups

Total number

Age

Male No. (%).

APACHE III score

Respiratory rate

PaO2/FiO2

PEEP

Bernard 1987

Steroid

50

55 ± 2

NA

NA

NA

NA

8 ± 1

Control

49

56 ± 2

NA

NA

NA

NA

7 ± 1

Meduri 1998

steroid

16

47 ± 3.9

5 (31%)

58(14)

NA

161(14)

12(1.2)

control

8

51 ± 6.6

4 (50%)

55(16)

NA

141(19)

14(1.7)

Confalonieri 2005

steroid

23

60.4 ± 17.3

17 (74%)

17.2 ± 4.1

NA

141 ± 49

NA

control

23

66.6 ± 14.7

15 (65%)

18.2 ± 4

NA

178 ± 58

NA

Annane 2006

steroid

85

61 ± 16

56 (66 %)

NA

18.5 ± 3

104 ± 42

6.8 ± 2.7

control

92

59 ± 18

65 (70%)

NA

17.9 ± 3.1

108 ± 45

7.4 ± 3

Steinberg 2006

steroid

89

49 ± 19

40 (45%)

87.6 ± 27.5

NA

126 ± 42

12.9 ± 5.6

control

91

49.2 ± 16.5

58 (64%)

84.6 ± 29.4

NA

126 ± 40

12.3 ± 4.7

Meduri 2007

steroid

63

50.1 ± 15.3

34 (54%)

60.2 ± 20.2

NA

118.4 ± 51.2

13 ± 5

control

28

53.2 ± 15.3

13 (46%)

57.9 ± 21

NA

125.9 ± 38.6

11.2 ± 4

Tongyoo 2016

steroid

98

64.5 ± 17.3

50 (51%)

21.7 ± 5.7

NA

175.4 ± 6.9

7.3 ± 3

control

99

64.3 ± 16

51 (52%)

21.9 ± 5.7

NA

172.4 ± 6.7

6.8 ± 2.5

Villar 2020

steroid

139

56 ± 14

96 (69%)

NA

23(5)

142.4 ± 37.3)

12.6 ± 2.7

control

138

58 ± 15

95 (69%)

NA

23(5)

143.5 ± 33.4

12.5 ± 2.6

  1. Data are provided number and percent (%) or mean ± SD. PaO2 partial pressure pf arterial oxygen, PEEP positive end expiratory pressure, FiO2 fraction of inhaled oxygen, APACHE acute physiologic and chronic health evaluation